India based pharmaceutical company, Aurobindo Pharma Limited has revised the timeline for completing its captive solar power arrangement and equity investment in Swarnaakshu Solar Power Private Limited. The company stated that the acquisition of up to a 26 % equity stake and the related power purchase agreement were expected to be completed on or before March 31, 2026. The revision followed delays linked to pending approval from the state government concerned for setting up the captive solar power plant. Earlier disclosures had indicated a target completion date of December 31, 2025. The company informed stock exchanges that the transaction remained subject to regulatory clearances and that the investment would be completed once approvals were received.